Search Results 121-130 of 25482 for alzheimers
Research. Researchers at Mayo Clinic study Alzheimer's disease, mild cognitive impairment, and other conditions that affect memory and thinking skills.
Lecanemab (Leqembi) is a medicine given to slow the progression of mild Alzheimer's disease (AD). This medicine reduces clumps of proteins called ...
For people with Alzheimer's disease or other disorders causing dementia, these skills will decline over time. Eventually, driving will not be an option. The ...
Are individuals who experience traumatic brain injury (TBI) at increased risk of Alzheimer's disease and related dementias (ADRD)? That's a question that ...
... Alzheimer's disease. It is the most potent genetic risk factor for Alzheimer's identified in the past 20 years. Mayo Clinic researcher Rosa Rademakers, Ph.D ...
About this study. There is evidence that neurodegenerative changes precede clinical symptoms in Alzheimer's disease by two decades (Villemagne et al, 2013).
Watch Mayo Clinic neurologist Ronald C. Petersen, M.D., Ph.D., talk about mild cognitive impairment on HBO — The Alzheimer's Project. Research Profiles. Edit ...
Alzheimer's is the most common memory disorder in the United States and affects more that 5.5 million people. The enzyme — known as BACE2 — destroys beta- ...
... Alzheimer's and other forms of dementia. One Mayo Clinic study found that older adults who regularly engaged in moderate exercise five or six times a week ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Hurry to 3X your gift’s impact on cancer research and care!